Registry of Lobbyists
Monthly communication reports in the last 6 months: 0
View all monthly communication reports: 3
| Subject matters | Details | Categories |
|---|---|---|
|
Economic Development, Health, International Trade, Research and Development, Science and Technology
|
Supporting the client in efforts to obtain funding through the the Strategic Investment Fund (SIF) program.
|
Grant, Contribution or Other Financial Benefit
|
End date of the last completed financial year: 2024-12-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| Innovation, Science and Economic Development Canada (ISED) | $913,068.00 | Yes |
Address:
661 University Ave #1002
Toronto, ON M5G 1M1
Canada
Telephone number:
416-978-3751
Michael May, President & Chief Executive Officer
Centre for Commercialization of Regenerative Medicine is not a subsidiary of any other parent companies.
Centre for Commercialization of Regenerative Medicine is not a coalition.
The activities of Centre for Commercialization of Regenerative Medicine are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Ingrid Ravary-Konopka | Public offices held
Firm: Sussex Strategy Group